Kayentis and RWS partner to improve clinical trial data reliability in CNS studies
Integrated eCOA technology and rater training aim to reduce variability and strengthen ClinRO outcomes
Integrated eCOA technology and rater training aim to reduce variability and strengthen ClinRO outcomes
To boost compostable packaging, resin innovation, and supply chain speed
CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing
CDSCO-cleared BSM-5700 series targets ICU, NICU, ER, OR and digital health integration under ABDM
Effective recovery at home begins with well-defined care plans that outline treatment protocols, recovery milestones, and monitoring requirements tailored to individual patient needs
A brand from Opella will be part of the official NASA astronaut formulary
36 districts to get advanced ALS, BLS and neonatal ambulances under MEMS 108
Surgeon Yuvaraja operates on a 55-year-old patient at Medical City Hospital Muscat
In just the last few days, companies including Lupin, Biocon, Alembic Pharmaceuticals and Aurobindo Pharma have announced approvals for 5 mg and 10 mg tablets, all bioequivalent to Farxiga
Subscribe To Our Newsletter & Stay Updated